• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

Introduction to 4,6-dichloro-3-Pyridazinamine (CAS No. 1161847-28-4)

4,6-dichloro-3-Pyridazinamine, identified by its Chemical Abstracts Service (CAS) number 1161847-28-4, is a significant compound in the realm of pharmaceutical and agrochemical research. This heterocyclic amine derivative has garnered attention due to its versatile structural framework, which makes it a valuable scaffold for developing novel bioactive molecules. The presence of chlorine substituents at the 4 and 6 positions, coupled with the pyridazine core, enhances its reactivity and potential utility in synthetic chemistry.

The compound’s molecular structure, characterized by a six-membered ring containing two nitrogen atoms and two chlorine atoms, imparts unique electronic and steric properties. These features are particularly advantageous in medicinal chemistry, where precise control over molecular interactions is crucial for drug design. The pyridazine moiety is known for its stability and compatibility with various functional groups, making it a preferred choice for medicinal chemists seeking to develop inhibitors or activators of biological targets.

In recent years, 4,6-dichloro-3-Pyridazinamine has been extensively studied for its potential applications in the treatment of various diseases. One of the most promising areas of research is its role as an intermediate in the synthesis of kinase inhibitors. Kinases are enzymes that play a pivotal role in cell signaling pathways, and their dysregulation is associated with numerous diseases, including cancer. By targeting specific kinases, compounds derived from 4,6-dichloro-3-Pyridazinamine could offer therapeutic benefits by modulating these pathways.

Recent studies have highlighted the compound’s efficacy in preclinical models as a lead candidate for further development. Researchers have demonstrated that derivatives of 4,6-dichloro-3-Pyridazinamine can selectively inhibit certain kinases while minimizing off-target effects. This selectivity is critical for reducing side effects and improving patient outcomes. The chlorine substituents in the molecule contribute to this selectivity by enhancing binding affinity to the active site of the target kinase.

Moreover, the agrochemical industry has shown interest in 4,6-dichloro-3-Pyridazinamine due to its potential as a precursor for herbicides and pesticides. The structural features of this compound allow for modifications that can enhance its bioactivity against unwanted plants or pests. By leveraging its reactivity, chemists can design molecules that are more effective at lower concentrations, thereby reducing environmental impact.

The synthesis of 4,6-dichloro-3-Pyridazinamine involves multi-step organic reactions that require careful optimization to ensure high yield and purity. Common synthetic routes include chlorination of pyridazine derivatives followed by amination at the 3-position. Advances in catalytic methods have improved the efficiency of these processes, making it more feasible to produce larger quantities of the compound for research purposes.

In conclusion, 4,6-dichloro-3-Pyridazinamine (CAS No. 1161847-28-4) is a multifaceted compound with significant potential in pharmaceutical and agrochemical applications. Its unique structural features and reactivity make it an attractive scaffold for developing novel bioactive molecules. As research continues to uncover new therapeutic targets and synthetic strategies, the importance of this compound is likely to grow further.

• 5469-69-2(3-Amino-6-chloropyridazine)
• 2645413-09-6(6-chloropyridazin-4,5-d2-3-amine)
• 1353101-17-3(4-Chloropyridazin-3-amine)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)